Insider Trading History of Ben-maimon Carole

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ben-maimon Carole since 2013. This trader's CIK number is 1529611. At the time of last reporting, Ben-maimon Carole was the President and CEO of Larimar Therapeutics, Inc.. (stock ticker symbol LRMR). Also see all insider trading activities at Larimar Therapeutics, Inc..

Note that in the past BEN-MAIMON CAROLE also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Larimar Therapeutics, Inc. (LRMR) by Ben-maimon Carole

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 LRMR 5,000 $18,525 0 $0 0 $0
2022 LRMR 31,746 $99,999 0 $0 0 $0

Yearly summary of insider trading at Impax Laboratories Inc (IPXL) by Ben-maimon Carole

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 IPXL 0 $0 0 $0 12,016 $227,462

Yearly summary of insider trading at Teligent, Inc. (TLGT) by Ben-maimon Carole

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 TLGT 10,000 $5,890 0 $0 0 $0


Insider trading activities at 3 companies by Ben-maimon Carole:

1. Larimar Therapeutics, Inc. (LRMR)

2. Impax Laboratories Inc (IPXL)

3. Teligent, Inc. (TLGT)

Table 1. Insider trading of Larimar Therapeutics, Inc. (LRMR) by Ben-maimon Carole

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-05-17 LRMR Buy 5,000 3.71 18,525
2022-09-16 LRMR Buy 31,746 3.15 99,999

Table 2. Insider trading of Impax Laboratories Inc (IPXL) by Ben-maimon Carole

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-10-25 IPXL Option Ex 6,734 18.93 127,474
2013-10-10 IPXL Option Ex 5,282 18.93 99,988

Table 3. Insider trading of Teligent, Inc. (TLGT) by Ben-maimon Carole

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-30 TLGT Buy 10,000 .59 5,890

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ben-maimon Carole (President and CEO of Larimar Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.